Wednesday, July 8, 2026
🇺🇸 FDA

biotech · Alzheimer Disease · Major Depressive Disorder · CGTX

Cognition Therapeutics

COGNITION THERAPEUTICS INC

Cognition Therapeutics trial registry — 36 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
2500 Westchester Ave, Purchase, New York 10577, US HQ
2007 Founded
32 Employees
Public company Type
CGTX · NYSE Ticker
Company details
Status
Public
HQ
2500 Westchester Ave, Purchase, New York 10577, US
Founded
2007
Employees
32
Programs
33
Drugs
26
Patents
12
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Trials

Cognition Therapeutics clinical trials

Registry index of 36 ClinicalTrials.gov studies linked to Cognition Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Cognition Therapeutics trial registry — 36 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Cognition Therapeutics.

  1. UCAB-CT-05 — Phase 2

    Clinical update

  2. The Modular Protocol for Mental Health — Phase 2

    Clinical update

  3. Oxytocin nasal spray — Phase 2

    Clinical update

  4. Oxytocin nasal spray — Phase 2

    Clinical update

  5. Dexmedetomidine — Phase 2

    Clinical update

  6. Citalopram — Unknown

    Clinical update

  7. Autobiographical Memory Flexibility (MemFlex) training — Phase 2

    Clinical update

  8. Active Treatment- CT1812 100 mg — Phase 2

    Clinical update

Trial registry

36 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.